# Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection

> **NCT07714577** · NA · NOT_YET_RECRUITING · sponsor: **Tianjin First Central Hospital** · enrollment: 200 (estimated)

## Conditions studied

- HPV16/18 Positive

## Interventions

- **DRUG:** BBM-C101

## Key facts

- **NCT ID:** NCT07714577
- **Lead sponsor:** Tianjin First Central Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2030-08-01
- **Final completion:** 2031-08-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07714577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07714577, "Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07714577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*